Synthesis and biological activity of 3,4-dihydroquinazolines for selective T-type Ca2+ channel blockers.Bioorg Med Chem Lett. 2005 Jan 17; 15(2):283-6.BM
Abstract
We have synthesized 3,4-dihydroquinazoline derivatives for the potent and selective T-type Ca(2+) channel blockers and evaluated for their inhibitory activities against two subtypes T-type Ca(2+) channels and N-type Ca(2+) channels. Among them, 5b (KYS05044, IC(50)=0.56+/-0.10 microM) was identified as potent T-type Ca(2+) channel blocker with in vitro selectivity profile at meaningful level (T/N-type, SI=>100).
MeSH
Pub Type(s)
Journal Article
Research Support, Non-U.S. Gov't
Language
eng
PubMed ID
15603940
Citation
Rhim, Hyewhon, et al. "Synthesis and Biological Activity of 3,4-dihydroquinazolines for Selective T-type Ca2+ Channel Blockers." Bioorganic & Medicinal Chemistry Letters, vol. 15, no. 2, 2005, pp. 283-6.
Rhim H, Lee YS, Park SJ, et al. Synthesis and biological activity of 3,4-dihydroquinazolines for selective T-type Ca2+ channel blockers. Bioorg Med Chem Lett. 2005;15(2):283-6.
Rhim, H., Lee, Y. S., Park, S. J., Chung, B. Y., & Lee, J. Y. (2005). Synthesis and biological activity of 3,4-dihydroquinazolines for selective T-type Ca2+ channel blockers. Bioorganic & Medicinal Chemistry Letters, 15(2), 283-6.
Rhim H, et al. Synthesis and Biological Activity of 3,4-dihydroquinazolines for Selective T-type Ca2+ Channel Blockers. Bioorg Med Chem Lett. 2005 Jan 17;15(2):283-6. PubMed PMID: 15603940.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Synthesis and biological activity of 3,4-dihydroquinazolines for selective T-type Ca2+ channel blockers.
AU - Rhim,Hyewhon,
AU - Lee,Yong Sup,
AU - Park,Seong Jun,
AU - Chung,Bong Young,
AU - Lee,Jae Yeol,
PY - 2004/09/16/received
PY - 2004/10/28/accepted
PY - 2004/12/18/pubmed
PY - 2005/6/29/medline
PY - 2004/12/18/entrez
SP - 283
EP - 6
JF - Bioorganic & medicinal chemistry letters
JO - Bioorg Med Chem Lett
VL - 15
IS - 2
N2 - We have synthesized 3,4-dihydroquinazoline derivatives for the potent and selective T-type Ca(2+) channel blockers and evaluated for their inhibitory activities against two subtypes T-type Ca(2+) channels and N-type Ca(2+) channels. Among them, 5b (KYS05044, IC(50)=0.56+/-0.10 microM) was identified as potent T-type Ca(2+) channel blocker with in vitro selectivity profile at meaningful level (T/N-type, SI=>100).
SN - 0960-894X
UR - https://www.unboundmedicine.com/medline/citation/15603940/Synthesis_and_biological_activity_of_34_dihydroquinazolines_for_selective_T_type_Ca2+_channel_blockers_
DB - PRIME
DP - Unbound Medicine
ER -